You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T-Large Granulocytic Leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cutaneous T-cell Lymphoma, T-Prolymphocytic Leukemia, T-Large Granulocytic Leukemia Trial in Columbus (Romidepsin, Busulfan,

Recruiting
  • Cutaneous T-cell Lymphoma
  • +4 more
  • Columbus, Ohio
    The Ohio State University Cancer Center
Apr 18, 2022

Relapsed/Refractory Large Granular T Lymphocytic Leukemia Trial in Zhoukou, Tianjin (Linperlisib)

Not yet recruiting
  • Relapsed/Refractory Large Granular T Lymphocytic Leukemia
  • Zhoukou, Henan, China
  • +1 more
Dec 22, 2022

B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • CD19/CD22-bispecific CAR-T cells
  • Beijing, Beijing, China
    Liang Wang
Oct 7, 2023

T-Cell Large Granular Lymphocyte Leukemia Trial in Columbus (Ruxolitinib)

Not yet recruiting
  • T-Cell Large Granular Lymphocyte Leukemia
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Oct 20, 2022

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Tampa (Fludarabine, Cyclophosphamide,

Recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 12, 2023

Non Hodgkin Lymphoma (NHL), Peripheral T-cell Lymphoma (PTCL), Cutaneous T-Cell Lymphoma (CTCL) Trial in United States (KT-333)

Recruiting
  • Non Hodgkin Lymphoma (NHL)
  • +4 more
  • Orange, California
  • +8 more
Nov 29, 2022

T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

Not yet recruiting
  • T-Cell Non-Hodgkin Lymphoma
  • +14 more
  • WU-CART-007
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 17, 2023

CLL, SLL, HCL Trial in Dresden

Recruiting
  • CLL
  • +7 more
    • Dresden, Sachsen, Germany
      BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
    Apr 29, 2022

    T-Cell Large Granular Lymphocyte Leukemia Trial in Columbus (Oral Azacitidine)

    Recruiting
    • T-Cell Large Granular Lymphocyte Leukemia
    • Oral Azacitidine
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Apr 18, 2022

    T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

    Recruiting
    • T-cell Lymphoma
    • +30 more
    • Optional Blood Sample
    • Optional Nail Sample
    • Duarte, California
    • +25 more
    Jul 28, 2023

    Aggressive NK Cell Leukemia Trial in Hiroshima (PPMX-T003)

    Recruiting
    • Aggressive NK Cell Leukemia
    • Hiroshima, Japan
      Hiroshima University Hospital
    May 9, 2023

    T Lymphoblastic Leukemia/Lymphoma, T-cell Acute Lymphoblastic Leukemia, Peripheral T Cell Lymphoma Trial in Shanghai (anti-CD7

    Recruiting
    • T Lymphoblastic Leukemia/Lymphoma
    • +4 more
    • anti-CD7 CAR-T cells
    • Shanghai, China
      Xianmin General Song
    Aug 29, 2022

    Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem

    Not yet recruiting
    • Hematologic Malignancy
    • +5 more
    • autologous hematopoietic stem cells added to planned CAR T
    • Los Angeles, California
      Cedars-Sinai Medical Center
    May 31, 2023

    LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous T-Cell Lymphoma - Category, Primary Cutaneous CD8-Positive

    Recruiting
    • LGLL - Large Granular Lymphocytic Leukemia
    • +13 more
    • Duarte, California
    • +9 more
    Aug 9, 2022

    NHL, Relapsed, Adult, B-cell Lymphoma, B-cell Leukemia Trial (KUR-502)

    Not yet recruiting
    • NHL, Relapsed, Adult
    • +3 more
    • KUR-502
    • (no location specified)
    Aug 2, 2022

    Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Transformed Chronic

    Not yet recruiting
    • Recurrent Transformed Chronic Lymphocytic Leukemia
    • +7 more
    • Biospecimen Collection
    • +9 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    May 15, 2023

    People Living With HIV Treated With CD19-directed CAR T Cell

    Active, not recruiting
    • Leukemia
    • +9 more
      • Philadelphia, Pennsylvania
        Pennsylvania Hospital
      Mar 29, 2023

      Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • +11 more
      • Zilovertamab vedotin
      • Duarte, California
      • +13 more
      Jan 12, 2023

      Venetoclax Tablets Crushed and Dissolved Into a Solution

      Not yet recruiting
      • Hematologic Malignancy
      • +18 more
      • 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      Nov 8, 2023

      B-Cell Lymphoma, B Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Pittsburgh (Chimeric Antigen Receptor

      Recruiting
      • B-Cell Lymphoma
      • +8 more
      • Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
      • Pittsburgh, Pennsylvania
        AHN Cancer Institute - West Penn Hospital
      Aug 10, 2022

      Lymphoblastic Leukemia, Lymphoblastic Leukemia in Children, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (Anti-CD19

      Recruiting
      • Lymphoblastic Leukemia
      • +5 more
      • Anti-CD19 CAR T-cells
      • Singapore, Singapore
      • +1 more
      Dec 4, 2022

      Bio-CAR-T BS Study

      Recruiting
      • Diffuse Large B Cell Lymphoma (DLBCL)
      • +2 more
        • Brescia, Italy
          ASST Spedali Civili di Brescia
        May 5, 2022

        (CHANT)Real World Study of Duvelisib in Treatment of

        Not yet recruiting
        • Follicular Lymphoma
        • +5 more
        • (no location specified)
        Jun 20, 2023

        Patients Previously Treated WithMustang Bio CAR-T Cell

        Enrolling by invitation
        • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
        • +10 more
        • Prior MB-102 CAR-T cell investigational product.
        • Prior MB-106 CAR-T cell investigational product.
        • Duarte, California
        • +4 more
        Dec 8, 2022

        Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed

        Not yet recruiting
        • Pediatric Cancer
        • +11 more
        • anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
        • Milwaukee, Wisconsin
          Children's Wisconsin
        Sep 14, 2022